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We have produced a monoclonal hybridoma cell line (SIBS) that secretes an IgGb immunoglobulin with 
a high affinity (& 0.38 x lo-” M) for 12sI-labelled sex hormone binding globulin (SHBG), and which 
will specifically immunoprecipitate SHBG from serum. The antibody is produced in high titre in culture 
medium and ascites fluid, and can be purified to apparent homogeneity by protein A affinity 
chromatography. When examined by isoelectrofocussing, a characteristic series of bands, which bind “‘I- 
SHBG, are observed at pH 8.5-9. Competitive, superimposable, displacement of ‘2’I-SHBG from the 
antibody is achieved with dilutions of human, chimpanzee and gorilla sera at comparable SHBG 
concentrations. Partial cross-reaction is observed with sera from other Old World primates, but not with 
sera from New World monkeys or any other vertebrate species studied. 
Monoclonal antibody Sex hormone 
1. INTRODUCTION 
Sex hormone binding globulin (SHBG) is a 
plasma glycoprotein that is considered to be an im- 
portant modulator of sex-steroid hormone entry 
into target cells. The protein has been purified to 
apparent homogeneity, and antisera of high quali- 
ty have been produced. These have been used to 
quantify the protein by various immunochemical 
methods [l-4], and to study its cellular and 
subcellular localization [5,6]. Some of the antisera 
produced to date appear to exhibit monospecific 
qualities, but the possibility exists that subpopula- 
tions of antibodies directed against minor ‘con- 
taminants may elude detection by conventional im- 
munoelectrophoretic techniques. It is mainly for 
this reason that immunochemical evidence for 
target cell internalization of SHBG [5] has been 
received with scepticism. 
Abbreviation: SHBG, sex hormone binding globulin; 
also known as testosterone-estradiol binding globulin 
(TeBG) and sex-steroid binding protein (SBP) 
Binding globulin Phylogeny 
The generation and careful characterization of 
monoclonal antibodies to SHBG will undoubtedly 
help resolve questions to specificity in im- 
munocytochemical studies, and may also clarify 
the controversy associated with estimates of SHBG 
molecular mass and subunit structure [7]. In addi- 
tion, they will also facilitate the development of 
immunometric assays and obviate the requirement 
for pure SHBG as either standard or labelled 
ligand. 
2. MATERIALS AND METHODS 
2.1. Purification of SHBG 
Human SHBG was purified from pooled 
pregnancy serum, essentially as in [8]. Briefly, 0.5 1 
serum was applied to a 30 x 5 cm 
DEAE-Sepharose CL6B (Pharmacia, Uppsala) 
ion-exchange column, which was washed with 
0.1 M Tris-HCl (pH 8.5), 0.02 M KC1 and then 
eluted with a 0.02-0.40 M KC1 gradient, 
developed in the same buffer. Fractions containing 
SHBG binding activity [9] were pooled, and ap- 
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plied to a 10 x 2.6 cm affinity column of 3-0x0- 
17,i%hydroxy-%androstane- 17cu-(6-hexyn- l-01) co- 
valently linked to diaminoethyloxirane Sepha- 
rose CL4B. The column was washed with 0.1 M 
Tris-HCl (pH 7.5), 0.5 M KCl, 10% dimethylfor- 
mamide (TKD) buffer until absorbance at 280 nm 
was negligible, incubated at 25°C for 1 h with a 
column volume of TKD buffer containing 4Opg 
Scu-dihydrotestosterone (DHT)/ml, and then 
eluted with TKD buffer. Fractions containing 
SHBG were pooled, concentrated by ultrafiltration 
using an Amicon PM10 filter (Amicon Corp., 
MA), and subjected to preparative polyacrylamide 
gel electrophoresis (PAGE) (BRL Inc., Bethesda). 
A 3100-fold purification of SHBG was obtained 
from the starting material, at a yield of -20%. The 
protein was judged pure by analytical PAGE and 
SDS-PAGE, and a molecular mass of 50.5 kDa 
was estimated [lo]. 
2.2. Iodination of SHBG 
Purified SHBG was radioiodinated with N- 
succinimidyl-3-(4-hydroxy-5-[1z5I]iodophenyl)pro- 
pionate (Amersham, England) as in [l 11. The “‘I-_ 
SHBG was separated from small molecular mass 
radioiodinated complexes on a Sephadex G-100 
column (20 x 1 cm), pre-equilibrated with 50 mM 
phosphate buffer (pH 7.5), containing 0.25% 
gelatin as carrier protein, and then eluted with the 
same buffer. This method yields preparations of 
“‘I-SHBG with specific activities of 13-21 pCi/pg 
protein which appear to be >98% pure when ex- 
amined by agarose gel electrophoresis (see fig.3a), 
and which are stable during storage at -20°C for 
up to 2 months in 2% horse serum. 
2.3. Immunization and cell fusion 
Balb/C mice were immunized subcutaneously 
with 100 ,ug SHBG in Freund’s complete adjuvant. 
Antiserum titres were determined by incubation 
(16 h at 20°C) with 28000 dpm “‘1-SHBG, 
precipitation of antibody-bound complexes with 
4% rabbit anti-mouse IgG (RAM) antiserum in 
10% polyethylene glycol (PEG) 4000 by cen- 
trifugation (30 min at 3000 x g), and aspiration of 
supernatants to waste. In this way, titres of 1: 2000 
at 50% of maximum binding (Bma, = 18 500 dpm) 
were achieved 2 weeks after a single intraperitoneal 
(i.p.) booster (1Opg SHBG in incomplete Freund’s 
adjuvant). Three days after an intravenous injec- 
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tion of 1Olcg SHBG in physiological saline, spleen 
cells were isolated from the mouse with the highest 
serum titres, and fused [ 121 in the presence of 50% 
PEG 4000 with equal numbers (1.5 x 10’ cells) of 
X63-Ag8.653 myeloma cells which lack any expres- 
sion of immunoglobulin synthesis [13]. After fu- 
sion, cells were seeded onto 48 x 1 ml feeder layers 
containing 5 x lo5 spleen cells in HAT selection 
medium. On day 24 after fusion, 69% of wells ex- 
hibited vigorous hybridoma cell growth, 59% of 
which exhibited anti-SHBG antibody titres (as 
measured above) equivalent to 10-65‘70 of the 
maximum binding recorded for the immune 
serum. 
2.4. Cloning and monoclonal antibody 
production 
Wells containing hybridoma colonies secreting 
the highest titres of anti-SHBG antibodies were 
cloned and subcloned twice by the limiting dilution 
technique, using 2 x IO5 non-immune spleen cells 
as feeder layers. One particular clone (SIBS) ex- 
hibited expansive growth and produced a high an- 
tibody titre in culture media (1: 8000 or 10 mg an- 
tibody/l). Highly concentrated antibodies 
(1: 500000 or 0.8 g antibody/l) were also produced 
by collecting ascites fluid from pristane 
(2,6,10,14-tetramethylpentadecane) primed (1 ml 
i.p. 2 weeks before use) Balb/C mice injected (i.p.) 
with lo7 StBs cells. 
2.5. Demonstration of monoclonality 
Analytical isoelectrofocussing (IEF) was per- 
formed on prefocussed (1 h) thin-layer (0.5 mm) 
agarose gels containing 2% (w/v) polyampholytes 
(Serva, Heidelberg), pH 4-9 [14]. Samples of 
culture media (20 ~1) from several SiB5 sub-clones 
or ascitic fluid (5 ~1) were applied and subjected to 
IEF for 1 h at 6 W constant power (fig.la-c). The 
agarose gel was then blotted (90 min) with 
cellulose acetate paper (Cellagram II, Shandon 
Southern, USA) pre-soaked in a 1:2 dilution of 
RAM in 50 mM barbitone buffer (pH 8.6). After 
immunofixation, the gel was washed (16 h in 0.9% 
NaCI), blotted and dried prior to staining with 
Coomassie brilliant blue R250, and destained in 
ethanol-glacial acetic acid-water (35 : 10 :55, 
v/v/v). In some experiments i251-SHBG (lo6 
dpm/ml) was added to the immunofixation buffer 
to identify protein bands with binding affinity for 
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SHBG (fig. lc). After fixation these gels were auto- 
radiographed (96 h at 25’C) using Kodak X-Omat 
AR film (Eastman Kodak Co., Rochester, NY). 
2.6. Identification of Ig class and subclass 
The identity of the SIBS antibody im- 
munoglobulin class and subclass was ascertained 
by Ouchterlony type double immunodiffusion, us- 
ing specific antisera against mouse IgA, IgE, IgM, 
IgG, IgGl, IgGh, IgGw and IgG3 (Miles 
Laboratories, Slough, England and Nordic Im- 
munological Laboratories, Maidenhead, Eng- 
land). Immunoprecipitation arcs were observed 
only between SIBS and the IgG or IgGzc, antisera. 
2.1. Purification of monoclonal antibody 
Culture medium (500 ml) containing SiB5 an- 
tibody was applied at pH 8 to an affinity 
chromatography column (8 x 0.9 cm) of protein 
A-Sepharose CL4B (Pharmacia) at a flow rate of 
100 ml/h. The column was washed (20 ml/h) with 
50 ml of 0.14 M phosphate buffer (pH 8.0), 
followed by 10 ml of 0.1 M citrate buffer (pH 5.7), 
and then eluted with 10 ml of 0.1 M citrate buffer 
(pH 4.5). Eluate fractions (2 ml) were collected in 
tubes containing 0.4 ml of 1 M Tris-HCl (pH 9.0) 
and anti-SHBG antibody activity eluted as a single 
peak at pH 4.5. 
The purified SIBS antibody was subjected to 
analytical SDS-PAGE (T = 7.5(rlo, C = 2.5%). 
After staining with Coomassie brilliant blue R250 
and destaining with ethanol-acetic acid-water 
(30: 10:60, v/v/v), only two protein bands (cor- 
responding to molecular masses of 24.5 and 
57.5 kDa) were evident, and these are 
characteristic of the heavy and light chains of the 
IgG class of immunoglobulins. 
2.8. Antibody affinity and specificity 
Dilutions of S~BJ culture medium (1:800 
and 1:8000) were incubated with ‘251-SHBG 
(38000 dpm) for different time periods (0.25-4 h) 
at 20°C. Separation of bound and free i2’I-SHBG 
was accomplished by addition of an equal volume 
of 4% RAM in 10% PEG 4000, sedimentation of 
the insoluble antibody-bound complexes by cen- 
trifugation (3ooO x g, 30 min) and aspiration of 
the free fraction to waste. Under these conditions, 
equilibrium between antibody and ‘2SI-SHBG was 
achieved within 2 h at both antibody dilutions 
(fig.2a). The affinity of the SiB, antibody was 
determined as in [15]. A 1:800 dilution of S~BJ 
culture medium was incubated with 0.15-8.5 ng 
1251-SHBG (13 ,&i//cg protein), for 3 h at 2O”C, 
and separation of antibody-bound 1251-SHBG was 
accomplished as described above. The Scatchard 
plot indicates the presence of a single class of 
saturable high-affinity binding sites with a 
dissociation rate constant (&) of 0.38 X lO_” M 
(fig.2b). 
To demonstrate that the SIBS antibody 
recognizes active SHBG, 100 ~1 of a 1: 25 dilution 
of human pregnancy serum were incubated (16 h 
at 20°C) with 100~1 of dilutions (1: 100) of an 
SlBs ascitic fluid or a control non-immune ascitic 
fluid, and the DHT binding capacities of the super- 
natants were measured after immuno-precipitation 
of antibody-bound complexes with 4% RAM and 
10% PEG, as described above. In this way it could 
be shown that the SIBS antibody specifically 
removed > 95% of the SHBG binding activity pre- 
sent in the sample. 
To assess further the specificity of the SlBs an- 
tibody, a 1: 50 dilution of human pregnancy serum 
was ‘251-labelled as described above (section 2.2), 
and -7 x lo5 dpm of 1251-SHBG were added to a 
similar amount of the ‘251-labelled serum proteins. 
This was incubated (16 h at 20°C) with a 1 ml 
slurry of SiBs antibody immobilized on 
carbodiimidazole-activated, microparticulate cel- 
lulose (SIBs-Ab-cellulose, 40 mg/ml) [161, and 
then washed sequentially with 0.9% NaCl (3 x 
1 ml), 50 mM barbitone buffer (pH 8.6; 2 x 1 ml), 
0.9% NaCl(3 x 1 ml), 0.14 M phosphate-buffered 
saline (pH 7.4, 1 ml), and 0.9010 NaCl (2 x 1 ml), 
at 20°C. Antibody-bound complexes were then 
competitively displaced by incubation (16 h at 
20°C) with 20~1 of the diluted serum used for 
iodination plus 10 pg SHBG. After centrifugation 
(3000 x g for 5 min) a sample (5 ~1) of the superna- 
tant (-100,ul) was analysed by SDS-PAGE (7.5% 
T, 2.5% C) after heating at 100°C for 5 min in 1% 
SDS + 1% mercaptoethanol, using ‘251-SHBG and 
the 1251-labelled serum protein mixture as reference 
material. After electrophoresis was completed 
(3 h), gels were sliced (3 mm) and counted for “‘1 
(fig.3). 
A study was also conducted to assess the 
phylogenic specificity of the SlBs epitope, in which 
100 ~1 of a 1:2 dilution of SIBS-Ab-cellulose 
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(20 mg/ml) and “‘1-SHBG (42000 dpm) were in- 
cubated (16 h at 20°C) together with serial dilu- 
tions of human sera or plasma/serum samples 
from non-human primates and representative x- 
amples of other mammalian and sub-mammalian 
species. The Sa-dihydrotestosterone (DHT) bind- 
ing capacities of human and primary samples 
were determined taking into account species dif- 
ferences in the ‘off-rate’ of DHT at 0°C [9], and 
used to evaluate their immuno-crossreactivity 
relative to DHT binding capacity (fig.4). 
3. RESULTS AND DISCUSSION 
Established cell fusion and cloning techniques 
[ 121 have been used to produce a monoclonal 
hybridoma cell line (SIBS) that secretes an antibody 
with high affinity and specificity for sex hormone 
binding globulin. The selection of SiBs was based 
on the criteria that it exhibited vigorous growth, 
and produced high titres of an antibody capable of 
immunoprecipitating > 50% of the maximum 
amount of “‘1SHBG bound by the immune 
Fig.1. Isoelectrofocussing (IEF) of SIBS culture media 
and ascitic fluid. (a) Culture media from several sister 
subclones of SIBS (I-III) were subjected to IEF (pH 
4-9) individually or as mixtures, and then immunofixed 
with rabbit anti-mouse IgG antiserum (RAM); (b) ascitic 
fluid from a pristane-primed mouse injected with SiBs 
cells (i) and SiBs antibody purified from this ascitic fluid 
by protein A-Sepharose affinity chromatography and 
immunofixed with RAM (ii); (c) SIBS antibody 
immunofixed with RAM (i) and the same antibody 
immunofixed with a mixture of 12*1-SHBG and RAM 
(ii). A, application point. See section 2.5 for additional 
details. 
4 
2 
Time (h) 
Fig.2. Equilibrium time course (a) and Scatchard analysis (b) of the binding of ‘2SI-SHBG to SiBs antibody, The 
equilibrium time course was determined at two different culture medium dilutions [(a) 1: 800, (k) 1: SOOO], while 
Scatchard analysis was performed using a 1: 800 dilution of culture medium; B/F represents the bound/free ratio. See 
section 2.8 for additional details. 
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serum. Several other cell lines were derived by 
repeated cloning and selection, but the antibody 
titres produced by these clones were rarely 
> 1: 100. Although these antibodies bound -20% 
of the lz51-SHBG used in the screening assay, and 
could be displaced by the SHBG used as antigen or 
a 1: 10 dilution of pregnancy serum, they were 
unable to immunoprecipitate SHBG from serum. 
Further characterization of these clones and their 
antigenic determinants is in progress. It is, 
however, pertinent to note that although the 
SHBG used for immunization and antibody detec- 
tion was judged to be pure by PAGE and 
SDS-PAGE, subsequent immunoelectrophoretic 
analysis of a polyvalent antiserum raised in a rab- 
bit against this antigen revealed the presence of 
several other contaminating antigens [ 171. These 
contaminants must therefore have been present in 
very low amounts relative to SHBG, but at suffi- 
cient concentrations to evoke an immune response. 
Despite rigorous sub-cloning, it was considered 
essential to demonstrate monoclonality by an alter- 
native method. This was done by comparing the 
isoelectric spectra of antibodies produced by 
several sister sub-clones of SIBS. As shown in 
fig.la, the same characteristic, microhetero- 
geneous, isoelectric spectrum was found when 
these antibodies were examined individually or as 
mixtures. Moreover, each band was capable of 
binding 1251-SHBG (fig.lc). This phenomenon of 
microheterogeneity of antibodies produced by 
monoclonal cell lines is well known, and is thought 
to be generated by post-synthetic modification of 
the protein, resulting in changes uch as the loss of 
amide groups from glutamine or asparagine, or 
differences in acidic charge associated with 
variable amounts of sialic acid residues [ 181. These 
data, together with the observation that high titres 
of SrBs antibody were identified in all (24/24) wells 
which contained apparently clonal SIBS hybridoma 
colonies after repeated cloning, indicate that the 
SIBS cell line is monoclonal. 
Several other discrete isoelectric spectra were 
observed in ascitic fluid produced by tumours of 
SIBS (fig.lb), and undoubtedly reflect contamina- 
tion by endogenous mouse immunoglobulins. 
However, SrBs antibody can be conveniently 
purified to apparent homogeneity (see section 2.7) 
from culture media or ascitic fluid (fig.lb) by pro- 
tein A-Sepharose affinity chromatography [ 191, 
and its potential as an immunochemical probe may 
be anticipated by virtue of its particularly rapid 
rate of association (fig.2a) and high affinity for 
SHBG (fig.2b) which are superior to any of the 
polyvalent rabbit antisera we have obtained [17]. 
The SrBs antibody not only recognizes a discrete 
epitope on human SHBG, but unlike the 
1c 
5 
i i 
C] 
i 
I_ - 
&.tancZ trom Lgin$rn) 
f 
Fig.3. Demonstration that SIBS antibody specifically 
recognizes SHBG in a diluted serum sample. (a) Pure 
“‘1-SHBG, (b) mixture of ‘251-labelled proteins in a 
1: 50 dilution of human pregnancy serum + pure i2’1- 
SHBG and (c) 1251-labelled protein immunoabsorbed by 
SrB5 and then displaced with a mixture of 1: 50 dilution 
of human pregnancy serum + 10rg pure SHBG (see 
section 2.8 for details). The “‘1-1abelled proteins were 
analysed by SDS-PAGE after heating the samples 
(1OO’C for 5 min) in the presence of 1% SDS + 1% 
mercaptoethanol. The size of the gel slices was 3 mm 
and the position of the bromophenol blue (BPB) used as 
tracking dye is shown. 
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Fig.4. Competitive displacement curves of serum 
samples from humans and various primates. The relative 
amounts of SHBG in various samples are expressed in 
terms of DHT binding capacity (see section 2.8 for 
details). Human pregnancy (o), human male (o), male 
chimpanzee (+), gorilla (0), gibbon (*), Mucuc~ 
urctoides (O), Eryfhrucebus putus (a), woolly monkey 
(m), common marmoset (A), and ruffled lemur (0). 
Other species tested include: horse, wallaby, polar bear, 
tapir, deer, sheep, camel, bison, guinea pig, flamingo, 
tortoise, bullfrog, iguana and anaconda. 
polyvalent rabbit antisera we have generated it also 
does not interact with heat-denatured SHBG [ 171, 
and this implies a high degree of recognition for 
the tertiary structure of the molecule rather than a 
particular sequence of amino acids. In terms of 
species specificity, the exact molecular configura- 
tion of human SHBG, that is recognized by the 
SrB5 antibody, is also characteristic of SHBG in 
the chimpanzee and gorilla. The data also 
demonstrate that SHBGs in other Old World 
primates exhibit partial identity with the human 
SrB5 epitope, and it is interesting that SHBG in 
Old World monkeys cross-reacts less well than 
SHBG in the gibbon, which is evolutionarily more 
closely related to the great apes and man. 
However, in contrast to previous studies of the 
phylogenic specificity of polyvalent anti-human 
SHBG antisera [4,20], it is clear that the SrBs an- 
tibody does not cross-react with SHBG in New 
World monkeys or the lemur. 
In conclusion, the characteristics of the SIBS an- 
tibody indicate that it may represent an invaluable 
reagent for use as a labelled antibody in im- 
munometric assays and immunocytochemical 
localization studies and may also reveal informa- 
tion about the molecular structure of SHBG. 
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